Michele Janis MBA Net Worth

The estimated Net Worth of Michele Janis is at least $66.3 Thousand dollars as of 15 December 2022. Ms Janis owns over 1,015 units of OptiNose Inc stock worth over $45,013 and over the last 2 years she sold OPTN stock worth over $21,318.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms MBA OPTN stock SEC Form 4 insiders trading

Ms has made over 3 trades of the OptiNose Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she sold 1,015 units of OPTN stock worth $1,715 on 15 December 2022.

The largest trade she's ever made was selling 3,849 units of OptiNose Inc stock on 15 June 2022 worth over $13,433. On average, Ms trades about 2,201 units every 61 days since 2022. As of 15 December 2022 she still owns at least 48,927 units of OptiNose Inc stock.

You can see the complete history of Ms Janis stock trades at the bottom of the page.

Ms. Michele Janis MBA biography

Michele Janis MBA is the VP & Acting CFO at OptiNose Inc.

What's Ms MBA's mailing address?

Michele's mailing address filed with the SEC is C/O OPTINOSE, INC., 1020 STONY HILL ROAD, SUITE 300, YARDLEY, PA, 19067.

Insiders trading at OptiNose Inc

Over the last 19 years, insiders at OptiNose Inc have traded over $144,654,703 worth of OptiNose Inc stock and bought 116,688 units worth $814,936 . The most active insiders traders include Sriram Venkataraman, Capital Partners Ii Gp, Llc..., and Rajat Rai. On average, OptiNose Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,645. The most recent stock trade was executed by Anthony J Krick on 17 July 2024, trading 6,845 units of OPTN stock currently worth $7,803.

What does OptiNose Inc do?

optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo

Complete history of Ms Janis stock trades at OptiNose Inc

OptiNose Inc executives and stock owners

OptiNose Inc executives and other stock owners filed with the SEC include:

• Peter Miller,
  Chief Executive Officer, Director
• Ramy Mahmoud,
  President, Chief Operating Officer
• Michael Marino,
  Chief Legal Officer and Corporate Secretary
• Peter K. Miller,
  CEO & Director
• Keith Goldan,
  Chief Financial Officer
• Dr. Ramy A. Mahmoud M.D., M.P.H.,
  Pres & COO
• Michael F. Marino,
  Chief Legal Officer & Corp. Sec.
• Keith Alan Goldan,
  Chief Financial Officer
• Victor M. Clavelli,
  Chief Commercial Officer
• Michael F. Marino Esq.,
  Chief Legal Officer & Corp. Sec.
• Joseph Scodari,
  Independent Chairman of the Board
• Sandra Helton,
  Independent Director
• Wilhelmus Groenhuysen,
  Independent Director
• William Doyle,
  Independent Director
• Jonathan Neely,
  VP Investor Relations and Business Operations
• Catherine Owen,
  Director
• Victor Clavelli,
  Chief Commercial Officer
• Anthony Krick,
  VP & Chief Accounting Officer
• Michele Janis MBA,
  VP & Acting CFO
• Dr. Per Gisle Djupesland M.D., Ph.D.,
  Co-Founder & Chief Scientific Officer of OptiNose AS
• Helena Kyttari Djupesland,
  Co-Founder of Optinose AS (Norway) & Co-CEO of Optinose AS (Norway)
• John Messina,
  Sr. VP of Clinical Devel. & Medical Affairs
• Karen E. Brophy,
  VP of HR
• Paul Mastrapa,
  CFO
• John N Kapoor,
  Director
• Edward A Blechschmidt,
  Director
• Leo Henikoff,
  Director
• Kenneth Abramowitz,
  Director
• Jerome Sheldon,
  Director
• Rajat Rai,
  CEO
• Joseph Bonaccorsi,
  Secretary
• Richard M Smith,
  President & COO
• Capital Partners Ii Gp, Llc...,
  
• Ventures Llctkwd Ventures L...,
  
• Fund Lp Entrepreneurs Fund ...,
  
• Rick Bierly,
  Director
• Sriram Venkataraman,
  Director
• Larry G Pickering,
  Director
• Thomas Edward Gibbs,
  Chief Commercial Officer
• Joshua Alexander Tamaroff,
  Director
• Robert P O'neil,
  Director
• Ventures Llc Wfd,
  10% owner
• Ventures Llc Tkwd,
  10% owner
• Anthony J Krick,
  Chief Accounting Officer
• Tomas J. Heyman,
  Director
• Kyle Dempsey,
  Director
• Eric Bednarski,
  Director
• R John Fletcher,
  Director
• Paul Jr. Spence,
  Chief Commercial Officer
• Michele Janis,
  Acting Chief Financial Officer